|
| Exchange Received Time 30/07/2018 17:11:56 Exchange Disseminated Time 30/07/2018 17:12:02 Time Taken 00:00:06 | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2018 ,inter alias, to consider and approve 1.Considered and approved Un-Audited Financial Results as recommended by the Audit Committee for the quarter ended 30th June, 2018.
2.Placed and taken on record the Limited Review Report issued by the Statutory Auditor on Un-Audited Financial Results for the quarter ended 30th June, 2018.
3.The Board took on record the Corporate Governance Exemption Certificate for the Quarter ended 30th June, 2018 as per Regulation 15 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, which came into force on 01st December, 2015 certifying that Paid up equity capital of the Company is below Rs. 10 Crores and Net worth is below Rs. 25 Crores as on 31/03/2018.
4.The Board took on record Shareholding Pattern for the Quarter ended 30th June, 2018 under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
|
|
|